ombrabulin (AVE8062) / Sanofi  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ombrabulin (AVE8062) / Sanofi
DISRUPT, NCT01263886 / 2010-019384-11: Trial of Ombrabulin (AVE8062) in Combination With Taxane and Platinum in Patients With Non-small Cell Lung Cancer

Checkmark P2 data - ESMO 2012
Sep 2012 - Sep 2012: P2 data - ESMO 2012
Completed
2
176
US, Europe, RoW
ombrabulin (AVE8062), placebo
Sanofi
Non-small Cell Lung Cancer
03/12
10/12
OPSALIN, NCT01332656 / 2010-024631-16: Study of Ombrabulin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer Treated With Carboplatin/Paclitaxel

Completed
2
154
US, Europe, RoW
Ombrabulin (AVE8062), Placebo, Paclitaxel, Carboplatin
Sanofi
Ovarian Cancer Recurrent
07/14
07/14

Download Options